File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?

TitleLupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Authors
Issue Date2013
Citation
Clinical Journal of the American Society of Nephrology, 2013, v. 8 n. 1, p. 147-153 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/203152
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRovin, BHen_US
dc.contributor.authorParikh, SVen_US
dc.contributor.authorHebert, LAen_US
dc.contributor.authorChan, DTMen_US
dc.contributor.authorMok, CCen_US
dc.contributor.authorGinzler, EMen_US
dc.contributor.authorHooi, LSen_US
dc.contributor.authorBrunetta, Pen_US
dc.contributor.authorMaciuca, Ren_US
dc.contributor.authorSolomons, Nen_US
dc.date.accessioned2014-09-19T11:33:39Z-
dc.date.available2014-09-19T11:33:39Z-
dc.date.issued2013en_US
dc.identifier.citationClinical Journal of the American Society of Nephrology, 2013, v. 8 n. 1, p. 147-153en_US
dc.identifier.urihttp://hdl.handle.net/10722/203152-
dc.languageengen_US
dc.relation.ispartofClinical Journal of the American Society of Nephrologyen_US
dc.titleLupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?en_US
dc.typeArticleen_US
dc.identifier.emailChan, DTM: dtmchan@hku.hken_US
dc.identifier.authorityChan, DTM=rp00394en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.2215/CJN.03290412en_US
dc.identifier.pmid22879439-
dc.identifier.hkuros239892en_US
dc.identifier.volume8en_US
dc.identifier.issue1en_US
dc.identifier.spage147en_US
dc.identifier.epage153en_US
dc.identifier.isiWOS:000313221500022-
dc.identifier.f1000717954556-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats